13F

MDXG MIMEDX GROUP INC

2026Q1 · CUSIP 602496101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
235
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
119
Δ whales
+5
Inst. holding value
$446M
New positions
47
Closed positions
46
Price momentum (1Q)
-30.4%
Put / Call
3/2

Breadth history (34 quarters)

2018Q1: Δ-13 · h=223 2018Q2: Δ-13 · h=210 2018Q3: Δ-25 · h=185 2018Q4: Δ-149 · h=36 2019Q1: Δ-19 · h=17 2019Q2: Δ-1 · h=16 2019Q3: Δ+3 · h=19 2019Q4: Δ+0 · h=19 2020Q1: Δ+2 · h=21 2020Q2: Δ-2 · h=19 2020Q3: Δ+2 · h=21 2020Q4: Δ+88 · h=109 2021Q1: Δ+2 · h=111 2021Q2: Δ+29 · h=140 2021Q3: Δ+3 · h=143 2021Q4: Δ+10 · h=153 2022Q1: Δ-1 · h=152 2022Q2: Δ+1 · h=153 2022Q3: Δ-8 · h=145 2022Q4: Δ+9 · h=154 2023Q1: Δ+11 · h=165 2023Q2: Δ+13 · h=178 2023Q3: Δ+9 · h=187 2023Q4: Δ+13 · h=200 2024Q1: Δ+2 · h=202 2024Q2: Δ+1 · h=203 2024Q3: Δ-8 · h=195 2024Q4: Δ+20 · h=215 2025Q1: Δ+4 · h=219 2025Q2: Δ+5 · h=224 2025Q3: Δ+9 · h=233 2025Q4: Δ+1 · h=234 2026Q1: Δ+1 · h=235 2018Q1: holders=223 2018Q2: holders=210 2018Q3: holders=185 2018Q4: holders=36 2019Q1: holders=17 2019Q2: holders=16 2019Q3: holders=19 2019Q4: holders=19 2020Q1: holders=21 2020Q2: holders=19 2020Q3: holders=21 2020Q4: holders=109 2021Q1: holders=111 2021Q2: holders=140 2021Q3: holders=143 2021Q4: holders=153 2022Q1: holders=152 2022Q2: holders=153 2022Q3: holders=145 2022Q4: holders=154 2023Q1: holders=165 2023Q2: holders=178 2023Q3: holders=187 2023Q4: holders=200 2024Q1: holders=202 2024Q2: holders=203 2024Q3: holders=195 2024Q4: holders=215 2025Q1: holders=219 2025Q2: holders=224 2025Q3: holders=233 2025Q4: holders=234 2026Q1: holders=235 -149 -74.5 +0 +74.5 +149 14131247 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q2 Top 16% -9.1% +12.0%
2023Q1 Top 15% +28.7% +16.2%
2021Q2 Top 8% -30.9% -61.7%
2020Q4 Top 5% -4.8% +24.1%

Options Sentiment

Put holders
3
QoQ: 0
Call holders
2
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
21.0
EPS (TTM)
$0.20
EPS YoY
-25.9%
Revenue (TTM)
$0.4B
Revenue YoY
+10.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $67M 2022-09-30: $68M 2022-12-31: $74M 2023-03-31: $72M 2023-06-30: $81M 2023-09-30: $82M 2023-12-31: $87M 2024-03-31: $85M 2024-06-30: $87M 2024-09-30: $84M 2024-12-31: $93M 2025-03-31: $88M 2025-06-30: $99M 2025-09-30: $114M 2025-12-31: $118M 2026-03-31: $59M 2022-06-30: EPS -0.11 2022-09-30: EPS -0.09 2022-12-31: EPS -0.02 2023-03-31: EPS -0.06 2023-06-30: EPS 0.01 2023-09-30: EPS 0.06 2023-12-31: EPS 0.36 2024-03-31: EPS 0.06 2024-06-30: EPS 0.12 2024-09-30: EPS 0.05 2024-12-31: EPS 0.05 2025-03-31: EPS 0.05 2025-06-30: EPS 0.06 2025-09-30: EPS 0.11 2025-12-31: EPS 0.10 2026-03-31: EPS -0.07 0M 59M 118M $M -0.12 0.14 0.40 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 22 2023-12-31: PE 21.82024-03-31: PE 15.92024-06-30: PE 10.42024-09-30: PE 15.72024-12-31: PE 302025-03-31: PE 26.12025-06-30: PE 33.92025-09-30: PE 27.32025-12-31: PE 162026-03-31: PE 17.8 9 22 36 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)